Syncom Formulations (India) Balance Sheet
- Market cap
- ₹2,183 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹16.72 – ₹31.35
As of FY25, Syncom Formulations (India) had total assets of ₹1,419 crore and borrowings of ₹262 crore, against shareholders' equity of ₹1,102 crore — a debt-to-equity ratio of 0.35.
Syncom Formulations (India) balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 982 |
| Borrowings | 262 |
| Other liabilities | 175 |
| Total liabilities | 1,419 |
| Fixed assets | 764 |
| Capital work in progress | 45 |
| Investments | 327 |
| Other assets | 327 |
| Total assets | 1,419 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹8.15
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Syncom Formulations (India) balance sheet — frequently asked questions
What is the total debt of Syncom Formulations (India)?
Syncom Formulations (India) reported borrowings of ₹262 crore as of FY25.
What is Syncom Formulations (India)'s debt-to-equity ratio?
Based on the FY25 balance sheet, Syncom Formulations (India)'s debt-to-equity ratio is 0.35 — borrowings of ₹262 crore against equity capital and reserves of ₹1,102 crore.
What are Syncom Formulations (India)'s total assets?
Syncom Formulations (India)'s total assets were ₹1,419 crore as of FY25, including fixed assets of ₹764 crore and investments of ₹327 crore.
What is the book value per share of Syncom Formulations (India)?
The book value per share of Syncom Formulations (India) is ₹8.15, based on the latest reported balance sheet.
Same Data For Peers
Trade Syncom Formulations (India) With ATS
Track SYNCOMF live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.